The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
It extends a tumultuous period for UnitedHealth marked by the killing of a top executive, a costly cyberattack against its subsidiary and high medical costs.
U.S. Secretary of State Marco Rubio suggested that Ukraine’s Zelensky was not grateful for American support and was instead making “counterproductive” statements.